TGFB1 and chronic kidney disease: Sun et al. found that pioglitazone ameliorated mitochondrial dysfunction by inhibiting ROS production and protected the kidneys from fibrotic progression by reducing TGF-β1 signaling and fibronectin and collagen I levels in a CKD model of 5/6 nephrectomized rats [191].